AAAAAA

   
Results: 1-13 |
Results: 13
IMMUNOREACTIVITY OF BCL-2, P53 AND EGFR IS ASSOCIATED WITH TUMOR STAGE, GRADE AND CELL-PROLIFERATION IN SUPERFICIAL BLADDER-CANCER
Authors: LIUKKONEN TJO LIPPONEN PK HELLE M JAUHIAINEN KE ALAOPAS M TUHKANEN K FORSELL T GRANBACKA P HYNNINEN O JUUSELA H KEMPPAINEN P KORHONEN H LAHDESVASAMA T RANNIKKO S RUUTU M LEHTORANTA K TALJA M HAKKINEN J HALLSTROM P KONTTURI M LUKKARINEN O RAITANEN M NURMI M RAJALA P OTTELIN J PELLINEN P PERMI J PUOLAKKA VM RINTALA E TAMMELA TL TAINIO H USENIUS R
Citation: Tjo. Liukkonen et al., IMMUNOREACTIVITY OF BCL-2, P53 AND EGFR IS ASSOCIATED WITH TUMOR STAGE, GRADE AND CELL-PROLIFERATION IN SUPERFICIAL BLADDER-CANCER, Urological research, 25(1), 1997, pp. 1-7
TREATMENT OF HIGH-GRADE, HIGH-STAGE PROSTATE-CANCER WITH ESTRAMUSTINEPHOSPHATE OR DIETHYLSTILBESTROL - A DOUBLE-BLIND-STUDY
Authors: HEDLUND PO JACOBSSON H VAAGE S HAHNE B SANDIN T KONTTURI M NORDLE O ESPOSTI P PERMI J ALFTHAN O GIDLUND O HAGGMAN M JOHANSSON JE LUNDGREN R RASMUSSEN F TVETER K HAUKAAS S
Citation: Po. Hedlund et al., TREATMENT OF HIGH-GRADE, HIGH-STAGE PROSTATE-CANCER WITH ESTRAMUSTINEPHOSPHATE OR DIETHYLSTILBESTROL - A DOUBLE-BLIND-STUDY, Scandinavian journal of urology and nephrology, 31(2), 1997, pp. 167-172
ALTERNATING MITOMYCIN-C AND BACILLUS-CALMETTE-GUERIN INSTILLATION PROPHYLAXIS FOR RECURRENT PAPILLARY (STAGES TA TO T1) SUPERFICIAL BLADDER-CANCER
Authors: RINTALA E JAUHIAINEN K KAASINEN E NURMI M ALFTHAN O HANSSON E JUUSELA H KANERVA K KORHONEN H NURMI M PERMI J PETAYS P PUOLAKKA VM RAJALA P RUUTU M TAINIO H TALJA M TUHKANEN K VIITANEN J
Citation: E. Rintala et al., ALTERNATING MITOMYCIN-C AND BACILLUS-CALMETTE-GUERIN INSTILLATION PROPHYLAXIS FOR RECURRENT PAPILLARY (STAGES TA TO T1) SUPERFICIAL BLADDER-CANCER, The Journal of urology, 156(1), 1996, pp. 56-59
ALTERNATING MITOMYCIN-C AND BACILLUS-CALMETTE-GUERIN INSTILLATION PROPHYLAXIS FOR RECURRENT PAPILLARY (STAGES TA TO T1) SUPERFICIAL BLADDER-CANCER - REPLY
Authors: RINTALA E JAUHIAINEN K KAASINEN E NURMI M ALFTHAN O HANSSON E JUUSELA H KANERVA K KORHONEN H PERMI J PETAYS P PUOLAKKA VM RAJALA P RUUTU M TAINIO H TALJA M TUHKANEN K VIITANEN J
Citation: E. Rintala et al., ALTERNATING MITOMYCIN-C AND BACILLUS-CALMETTE-GUERIN INSTILLATION PROPHYLAXIS FOR RECURRENT PAPILLARY (STAGES TA TO T1) SUPERFICIAL BLADDER-CANCER - REPLY, The Journal of urology, 156(1), 1996, pp. 60-60
5-YEAR FOLLOW-UP OF A PROSPECTIVE TRIAL OF RADICAL CYSTECTOMY AND NEOADJUVANT CHEMOTHERAPY - NORDIC CYSTECTOMY TRIAL-I
Authors: MALMSTROM PU RINTALA E WAHLQVIST R HELLSTROM P HELLSTEN S HANNISDAL E ALFTHAN O RUSK J OPAS MA JAUHIAINEN K OTTELIN J PERMI J SALMELA H TAINIO H TALJA M TUHKANEN K VIITANEN J BREVIK B HOEG OM JOHANNESSEN NB FARSUND T MEDBY PC MURI O FOSSA SD OUS S SANDER S TVETER KJ OMLAND H STEINSVIK E URNES T WAALER G OGREID P OSTREM T ANDERSSON L EDSMYR F EKMAN P GUSTAFSON H NORMING U WIJKSTROM H KARLBERG L KIHL B LINDEBORG T
Citation: Pu. Malmstrom et al., 5-YEAR FOLLOW-UP OF A PROSPECTIVE TRIAL OF RADICAL CYSTECTOMY AND NEOADJUVANT CHEMOTHERAPY - NORDIC CYSTECTOMY TRIAL-I, The Journal of urology, 155(6), 1996, pp. 1903-1906
EFFICACY AND TOLERABILITY OF CASODEX IN PATIENTS WITH ADVANCED PROSTATE-CANCER
Authors: LUNGLMAYR G ALFTHAN O ALTWEIN JE BLACKLEDGE G BLACKLOCK NJ BONO A BOUFFIOUX C CHANNER K DEBRUYNE F DENIS L DISILVERIO F GRASSET D HAEFLINGER JM HARLAND S HEIJBROEK RP HOISAETER PA IVERSEN P JAEGER N KEUPPENS F KHOE GS KLARSKOV P KONTTURI M KUBER W KUMS JJM LARDENOYE JG LEDUC A LUNGLMAYR G MOEHRING K NEWLING D PAVONEMACALUSO M PERMI J RASMUSSEN F ROSSETTI SR SANDER S SARRAMON JP SMITH PH TVETER K TYRRELL CJ USAI E VALLANCIEN GMB VANCANGH PJ VARENHORST E WEISSBACH L WHELAN P WILLIAMS JL ZALCBERG J ZATTONI F DAWES PM
Citation: G. Lunglmayr et al., EFFICACY AND TOLERABILITY OF CASODEX IN PATIENTS WITH ADVANCED PROSTATE-CANCER, Anti-cancer drugs, 6(4), 1995, pp. 508-513
CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY
Authors: ANDERSEN JT EKMAN P WOLF H BEISLAND HO JOHANSSON JE KONTTURI M LEHTONEN T TVETER K BODKER A VEDEL O NORDLING J POULSEN AL SCHOU J HVIDT V HANSEN JB MEYHOFF HH ELDRUP J HARTWELL D COLSTRUP H LYNGDORF P NIELSEN AH LARSEN E WALTER S LARSEN EH THYBO E MOMMSEN S BROK KE PALM L GENSTER H ANDERSEN M KAUPPINEN P RAUVALA M HAKKINEN J TAMMELA T TAINIO H HYNNINEN O TIITINEN J LEHTORANTA K ALAOPAS M PERTTILA I PETAS A RINTALA E SALMINEN R JUUSELA H HANSSON E VONWENDT R TUHKANEN K TALJA M NURMI M PUNTALA P PERMI J PUOLAKKA VM VIITANEN J GISLASON T EINARSSON GV ERI LM KARLSEN S HOLME P SIVERTSEN SM STEINSVIK E SERVOLL E URNES T MALME PA JOHANSEN TEB OMLAND H NAGELHUS J KLOSTER SE SKJEGGESTAD O VADA K MORTENSEN R NYBERG G PETTERSSON G WEDMAN L BRATELL S FOLMERZ P ZACKRISSON B DAHLGREN K TILLEGARD A AUS G BERGDAHL S HUGOSSON J HOLMQUIST B EK A RADEMARK C KRISTIANSEN P HERMANSSON CG PEDERSEN K OSCARSSON C KIHL B OLSSON JO NELVIN L LEISSNER KH LUNDSTAM S HJERTBERG H VARENHORST E ANDERSSON SO WINDAHL T SWARTZ R AHLBERG B GEDDA S ANDERSTROM C EDDELAND S HANSSON R STROGERG P ADOLFSSON J BAUER P KLEIST H STORM B RANCH T STRAVSNES H BREKKAN E EKLUND T KARLBERG L MALICE MP BRONEE V WENNERLUND P ERIKSSON LO AASERUD E LEHMUSSAARI J SUOMIN R GABRIEL MA
Citation: Jt. Andersen et al., CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY, Urology, 46(5), 1995, pp. 631-637
ALTERNATING MITOMYCIN-C AND BACILLUS-CALMETTE-GUERIN INSTILLATION THERAPY FOR CARCINOMA IN-SITU OF THE BLADDER
Authors: RINTALA E JAUHIAINEN K RAJALA P RUUTU M KAASINEN E ALFTHAN O HANSSON E JUUSELA H KANERVA K KORHONEN H NURMI M PERMI J PETAYS P TAINIO H TALJA M TUHKANEN K VIITANEN J
Citation: E. Rintala et al., ALTERNATING MITOMYCIN-C AND BACILLUS-CALMETTE-GUERIN INSTILLATION THERAPY FOR CARCINOMA IN-SITU OF THE BLADDER, The Journal of urology, 154(6), 1995, pp. 2050-2053
STRESS-FRACTURE OF THE MEDIAL MALLEOLUS
Authors: ORAVA S KARPAKKA J TAIMELA S HULKKO A PERMI J KUJALA U
Citation: S. Orava et al., STRESS-FRACTURE OF THE MEDIAL MALLEOLUS, Journal of bone and joint surgery. American volume, 77A(3), 1995, pp. 362-365
EFFECTS OF ESTROGEN-TREATMENT ON SERUM GONADOTROPIN BIOACTIVITY, IMMUNOREACTIVITY AND ISOHORMONE DISTRIBUTION, AND ON IMMUNOREACTIVE INHIBIN LEVELS, IN PROSTATIC-CANCER PATIENTS
Authors: MATIKAINEN T HAAVISTO AM PERMI J DEKRETSER D HUHTANIEMI I
Citation: T. Matikainen et al., EFFECTS OF ESTROGEN-TREATMENT ON SERUM GONADOTROPIN BIOACTIVITY, IMMUNOREACTIVITY AND ISOHORMONE DISTRIBUTION, AND ON IMMUNOREACTIVE INHIBIN LEVELS, IN PROSTATIC-CANCER PATIENTS, Clinical endocrinology, 40(6), 1994, pp. 743-750
POLYESTRADIOL PHOSPHATE (160 MG MONTH) OR LHRH ANALOG (BUSERELIN DEPOT) IN THE TREATMENT OF LOCALLY ADVANCED OR METASTASIZED PROSTATIC-CANCER/
Authors: ARO J RUUTU M JUUSELA H HANSSON E PERMI J
Citation: J. Aro et al., POLYESTRADIOL PHOSPHATE (160 MG MONTH) OR LHRH ANALOG (BUSERELIN DEPOT) IN THE TREATMENT OF LOCALLY ADVANCED OR METASTASIZED PROSTATIC-CANCER/, Annales chirurgiae et gynaecologiae, 82, 1993, pp. 5-8
CLEAN INTERMITTENT SELF-CATHETERIZATION AFTER URETHROTOMY FOR RECURRENT URETHRAL STRICTURES
Authors: TAMMELA TLJ PERMI J RUUTU M TALJA M
Citation: Tlj. Tammela et al., CLEAN INTERMITTENT SELF-CATHETERIZATION AFTER URETHROTOMY FOR RECURRENT URETHRAL STRICTURES, Annales chirurgiae et gynaecologiae, 82, 1993, pp. 80-83
RANDOMIZED CONTROLLED-STUDY OF CHEMOPROPHYLAXIS IN TRANSURETHRAL PROSTATECTOMY
Authors: VIITANEN J TALJA M JUSSILA E NURMI M PERMI J PUOLAKKA VM RINTALA E SALMELA H TIITINEN J TUHKANEN K ELO J
Citation: J. Viitanen et al., RANDOMIZED CONTROLLED-STUDY OF CHEMOPROPHYLAXIS IN TRANSURETHRAL PROSTATECTOMY, The Journal of urology, 150(5), 1993, pp. 1715-1717
Risultati: 1-13 |